Exane Asset Management »

Apogee Therapeutics shares owned by Exane Asset Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Exane Asset Management from 13F filings

Historical chart of Exane Asset Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Exane Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Exane Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4M 52k 46.68
2024-09-30 $593k 10k 58.74

More positions owned by Exane Asset Management

CRH Stock (CRH)
Ferrovial Se Stock (FER)
JPMORGAN CHASE and Stock (JPM)
Pnc Financial Services Group I Stock (PNC)
Ubs Group Stock (UBS)
Smurfit Westrock Stock (SW)
Coca-Cola Europacific Partners Stock (CCEP)
Stellantis Nv Stock (STLA)
Boston Scientific Corp Stock (BSX)
Spotify Technology Sa Stock (SPOT)
Confluent Stock (CFLT)
Synopsys Stock (SNPS)
Apogee Therapeutics Stock (APGE)
Atlassian Corp Stock (TEAM)
Ccc Intelligent Solutions Hold Stock (CCCS)

View all positions for Exane Asset Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
Rtw Investments
BlackRock
Vanguard Group
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Paradigm Biocapital Advisors
Braidwell
Alliancebernstein
Perceptive Advisors
Citadel Advisors
Affinity Asset Advisors

View all funds holding Apogee Therapeutics